Large Molecule Bioanalysis done differently

To help you achieve more.

BioAgilytix has evolved the model for partnership in large molecule bioanalysis to benefit our customers and the patients they serve.

Services Delivered Scientist to Scientist

Our fully integrated GxP services are driven by your assay requirements and delivered by our veteran scientists – collaboratively, accurately, and on time.

Solutions Enabled by World-Leading Expertise

Our team is comprised of recognized experts in effectively navigating complex and evolving opportunities for biotherapeutics innovation.

usa europe labs

Advanced facilities to support all phases of large molecule global studies.

    LinkedIn Company Updates

  • 1 Day Agoview on linkedin


    Congratulations to our own Corinna Fiorotti on the recent publication of her article, “Immunogenicity considerations for antibody–drug conjugates: a focus on neutralizing antibody assays”, in Bioanalysis. You can access the full text here:

  • 1 Day Agoview on linkedin


    Much of what we do at BioAgilytix is powered by our science-minded, integrity-driven, and results-focused leadership team. Learn more about this group here:

  • 2 Days Agoview on linkedin


    A misshapen protein found in a rare type of childhood brain tumor, DIPG, has been successfully targeted by scientists at the University of California. The vaccine is currently undergoing a phase 1 trial. Learn more here: